We are international
Donate
TEXT SIZE   
   back

Dr. Liebisch - Prognostic Impact of Chromosomal Abnormalities in Elderly Patients with Multiple Myeloma Treated with High-Dose Melphalan (MEL140) and Autologous Stem Cell Transplantation
Peter Liebisch, MD
University Hospital of Ulm
Ulm, Germany
12.23.07

Be the first to comment

 related articles